Prepulse inhibition in patients with non-psychotic major depressive disorder

被引:43
|
作者
Perry, W [1 ]
Minassian, A [1 ]
Feifel, D [1 ]
机构
[1] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA
关键词
sensorimotor gating; prepulse inhibition; major depressive disorder; schizophrenia; inhibitory deficits;
D O I
10.1016/S0165-0327(03)00157-5
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Prepulse inhibition (PPI) of the startle response is a measure of sensorimotor gating. PPI deficits have been reported in schizophrenia and in patients characterized by a known dysfunction in the cortico-striato-pallido-thalamic (CSPT) brain substrates that regulate PPI. Patients with Major Depressive Disorder (MDD) are also thought to have impairment in the CSPT circuitry as they are characterized by clinical gating deficits. Therefore, we assessed PPI in non-psychotic MDD patients and compared their results to schizophrenia patients and non-patients. Method: PPI was assessed in 19 non-psychotic hospitalized MDD patients and compared to 14 hospitalized patients with schizophrenia and 13 archival normal comparison subjects. Results: MDD patients had PPI levels that were significantly higher than schizophrenia patients. The MDD subjects had PPI levels that were lower than non-patients but these differences were not statistically significant. Conclusions: MDD patients without psychosis do not exhibit PPI deficits comparable to schizophrenia patients. However, the MDD patients demonstrated a non-significant tendency towards lower PPI than the non-patients. Our results replicate previous findings that PPI deficits are found in acutely hospitalized schizophrenia patients, even when treated with atypical antipsychotic medication. Future studies with psychotic MDD patients are necessary to filly understand the relationship between MDD, psychosis, symptom severity and PPI. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:179 / 184
页数:6
相关论文
共 50 条
  • [1] Psychotic versus non-psychotic major depressive disorder: A comparative naturalistic study
    Buoli, Massimiliano
    Caldiroli, Alice
    Altamura, Alfredo Carlo
    [J]. ASIAN JOURNAL OF PSYCHIATRY, 2013, 6 (04) : 333 - 337
  • [2] Sex differences in psychotic and non-psychotic major depressive disorder in a Chinese Han population
    Qi, Ling
    Zhang, Yaping
    Wang, Liewei
    Wang, Ruoxi
    Wu, Jiang
    Zhou, Xin
    Chen, Jing
    Zhang, Shufang
    Zhou, Yongjie
    Zhang, Xiang Yang
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2020, 268 : 55 - 60
  • [3] A COMPREHENSIVE REVIEW OF EPIDEMIOLOGY AND ECONOMIC STUDIES FOR PATIENTS DIAGNOSED WITH NON-PSYCHOTIC MAJOR DEPRESSIVE DISORDER
    Greene, N.
    Greene, M.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A694 - A694
  • [4] The response of psychotic-like symptoms to fluoxetine monotherapy in non-psychotic major depressive disorder
    Dording, Christina M.
    Sinicropi-Yao, Lara
    Papakostas, George
    Matthews, John D.
    Nierenberg, Andrew A.
    Fava, Maurizio
    Mischoulon, David
    [J]. NORDIC JOURNAL OF PSYCHIATRY, 2009, 63 (05) : 420 - 425
  • [5] Psychological defense mechanisms and coping mechanisms in non-psychotic major depressive disorder
    I.Crasovan, Danut
    [J]. JOURNAL OF EDUCATIONAL SCIENCES & PSYCHOLOGY, 2013, 3 (02): : 89 - 98
  • [6] Empirical evidence for discrete neurocognitive subgroups in patients with non-psychotic major depressive disorder: clinical implications
    Pu, Shenghong
    Noda, Takamasa
    Setoyama, Shiori
    Nakagome, Kazuyuki
    [J]. PSYCHOLOGICAL MEDICINE, 2018, 48 (16) : 2717 - 2729
  • [7] Response to Treatment with Placebo, Medication or Psychotherapy in Severe Non-Psychotic Major Depressive Disorder
    Dunlop, Boadie W.
    Aaron, Margo H.
    [J]. CURRENT PSYCHIATRY REVIEWS, 2010, 6 (01) : 28 - 45
  • [8] Psychoticism dimension in a population of patients with non-psychotic major depression disorder
    Mantua, V.
    Calugi, S.
    Schiavi, E.
    Miniati, M.
    Cassano, G. B.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S385 - S385
  • [9] ECONOMIC BURDEN ASSOCIATED WITH DOSE-TITRATION AT INITIATION TO MANAGED CARE IN PATIENTS WITH NON-PSYCHOTIC MAJOR DEPRESSIVE DISORDER
    Camacho, F.
    Joish, V. N.
    Kong, M. C.
    Sheehan, D.
    Balkrishnan, R.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A490 - A490
  • [10] EVALUATION OF FACTORS AFFECTING TREATMENT RESPONSE AND RISK FACTORS FOR PATIENTS DIAGNOSED WITH NON-PSYCHOTIC MAJOR DEPRESSIVE DISORDER: A LITERATURE REVIEW
    Greene, N.
    Greene, M.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A693 - A694